Cargando…

Bumetanide As a Candidate Treatment for Behavioral Problems in Tuberous Sclerosis Complex

BACKGROUND: Recent studies indicate excitatory GABA action in and around tubers in patients with tuberous sclerosis complex (TSC). This may contribute to recurrent seizures and behavioral problems that may be treated by agents that enhance GABAergic transmission by influencing chloride regulation. C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vlaskamp, Chantal, Poil, Simon-Shlomo, Jansen, Floor, Linkenkaer-Hansen, Klaus, Durston, Sarah, Oranje, Bob, Bruining, Hilgo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596068/ https://www.ncbi.nlm.nih.gov/pubmed/28943860 http://dx.doi.org/10.3389/fneur.2017.00469

Ejemplares similares

Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot study
por: van Andel, Dorinde M., et al.
Publicado: (2020)

Bumetanide Effects on Resting-State EEG in Tuberous Sclerosis Complex in Relation to Clinical Outcome: An Open-Label Study
por: Juarez-Martinez, Erika L., et al.
Publicado: (2022)

Measurement of excitation-inhibition ratio in autism spectrum disorder using critical brain dynamics
por: Bruining, Hilgo, et al.
Publicado: (2020)

Single-case experimental designs for bumetanide across neurodevelopmental disorders: BUDDI protocol
por: Geertjens, Lisa, et al.
Publicado: (2022)

Bumetanide for Irritability in Children With Sensory Processing Problems Across Neurodevelopmental Disorders: A Pilot Randomized Controlled Trial
por: van Andel, Dorinde M., et al.
Publicado: (2022)

Behavioral disinhibition and antiepileptic treatment in childhood epilepsy: A retrospective cohort study
por: van Tuijl, Diana C., et al.
Publicado: (2017)

Detrended Fluctuation Analysis: A Scale-Free View on Neuronal Oscillations
por: Hardstone, Richard, et al.
Publicado: (2012)

Strong long‐range temporal correlations of beta/gamma oscillations are associated with poor sustained visual attention performance
por: Irrmischer, Mona, et al.
Publicado: (2017)

Long-Range Temporal Correlations in Alpha Oscillations Stabilize Perception of Ambiguous Visual Stimuli
por: Sangiuliano Intra, Francesca, et al.
Publicado: (2018)

Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage
por: Poil, Simon-Shlomo, et al.
Publicado: (2013)

Improved Manual Annotation of EEG Signals through Convolutional Neural Network Guidance
por: Diachenko, Marina, et al.
Publicado: (2022)

Sensory modulation disorders in childhood epilepsy
por: van Campen, Jolien S., et al.
Publicado: (2015)

EEG machine learning for accurate detection of cholinergic intervention and Alzheimer’s disease
por: Simpraga, Sonja, et al.
Publicado: (2017)

Following Excitation/Inhibition Ratio Homeostasis from Synapse to EEG in Monogenetic Neurodevelopmental Disorders
por: Geertjens, Lisa, et al.
Publicado: (2022)

Myelin Pathology Beyond White Matter in Tuberous Sclerosis Complex (TSC) Cortical Tubers
por: Mühlebner, Angelika, et al.
Publicado: (2020)

Bumetanide: Metabolic alkalosis: case report
Publicado: (2021)

Epilepsy, impaired functioning, and quality of life in patients with tuberous sclerosis complex
por: Vergeer, Menno, et al.
Publicado: (2019)

Is autism driven by epilepsy in infants with Tuberous Sclerosis Complex?
por: Moavero, Romina, et al.
Publicado: (2020)

Novel Histopathological Patterns in Cortical Tubers of Epilepsy Surgery Patients with Tuberous Sclerosis Complex
por: Mühlebner, Angelika, et al.
Publicado: (2016)

Bumetanide Exposure Association with Alzheimer’s Disease Risk
por: Graber-Naidich, Anna, et al.
Publicado: (2023)

Tuberous sclerosis
por: George, Anisha, et al.
Publicado: (2015)

External Drive to Inhibitory Cells Induces Alternating Episodes of High- and Low-Amplitude Oscillations
por: Avella Gonzalez, Oscar J., et al.
Publicado: (2012)

Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial
por: Kotulska, Katarzyna, et al.
Publicado: (2020)

XKR4 Gene Effects on Cerebellar Development Are Not Specific to ADHD
por: Shook, Devon, et al.
Publicado: (2017)

Peripheral bright streaks in tuberous sclerosis
por: Eliesersdóttir, Torgerð Hentze, et al.
Publicado: (2021)

Coding and small non-coding transcriptional landscape of tuberous sclerosis complex cortical tubers: implications for pathophysiology and treatment
por: Mills, James D., et al.
Publicado: (2017)

The epileptogenic zone in children with tuberous sclerosis complex is characterized by prominent features of focal cortical dysplasia
por: Hulshof, Hanna M., et al.
Publicado: (2021)

Off-Label Use of Bumetanide for Brain Disorders: An Overview
por: Kharod, Shivani C., et al.
Publicado: (2019)

Bumetanide for autism: Open‐label trial in six children
por: Fernell, Elisabeth, et al.
Publicado: (2021)

Bumetanide for neonatal seizures: No light in the pharmacokinetic/dynamic tunnel
por: Kaila, Kai, et al.
Publicado: (2022)

AUTISM IN TUBEROUS SCLEROSIS
por: Khanna, Rakesh, et al.
Publicado: (1991)

Tuberous sclerosis with rhabdomyoma
por: Ajay, V., et al.
Publicado: (2013)

Tuberous (or Tuberose) Sclerosis
por: Fowler, J. S., et al.
Publicado: (1910)

Tubers and Tumors Are CLIPped Together in Tuberous Sclerosis Complex
por: Dang, Louis
Publicado: (2022)

Specific pattern of maturation and differentiation in the formation of cortical tubers in tuberous sclerosis omplex (TSC): evidence from layer-specific marker expression
por: Mühlebner, Angelika, et al.
Publicado: (2016)

Author Correction: Coding and small non-coding transcriptional landscape of tuberous sclerosis complex cortical tubers: implications for pathophysiology and treatment
por: Mills, James D., et al.
Publicado: (2022)

All tubers are not created equal: Cerebellar tubers in a pediatric patient with tuberous sclerosis
por: Weerasinghe, Sanjeeva, et al.
Publicado: (2020)

A randomised controlled trial of bumetanide in the treatment of autism in children
por: Lemonnier, E, et al.
Publicado: (2012)

Bumetanide for autism: more eye contact, less amygdala activation
por: Hadjikhani, Nouchine, et al.
Publicado: (2018)

Failure of bumetanide to improve outcome after intracerebral hemorrhage in rat
por: Wilkinson, Cassandra M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_irh2935c8jp573lre79sp3lmts